Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
K-V Pharmaceutical Company
Case Number:
1:12-bk-13347
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
September 24, 2012
Bankrupt K-V Fights Hologic Bid To Reacquire Makena Rights
Ailing drugmaker K-V Pharmaceutical Co. on Thursday told a New York federal judge that creditor Hologic Inc. is trying to skirt bankruptcy law by seeking worldwide rights to Makena, a drug that prevents premature birth, and is wrongly suggesting the potential blockbuster medicine is rapidly losing value.
-
September 14, 2012
K-V Gets Judge's OK To Use Cash Collateral To Boost Biz
A New York bankruptcy judge on Friday approved K-V Discovery Solutions Inc.'s request to access its cash collateral after the life science company's largest creditor withdrew its objections to the motion.
-
September 06, 2012
Hologic Asks To Pursue Makena Claims Against K-V Pharma
K-V Pharmaceutical Co. creditor Hologic Inc. asked a New York bankruptcy judge Wednesday to lift the automatic stay so it could pursue its rights with respect to its first lien on K-V's biggest asset, preterm-birth drug Makena, saying the drug's value is declining.
-
August 09, 2012
K-V Pharma Wins Access To $31M In Cash Collateral
A New York bankruptcy judge on Thursday approved new debtor K-V Pharmaceutical Co.'s request to access $31.4 million in cash collateral to help it maneuver through the first 15 days of its bankruptcy and continue to pay employee wages and other necessary expenses.